A laboratory study finds that the approved kinase inhibitor lapatinib can improve retention of a nanoparticle sonosensitizer in hypoxic prostate...

A French early-access program of 3,709 patients with metastatic castration-resistant prostate cancer found that 177Lu-PSMA-617 produced efficacy and safety outcomes...

Epstein-Barr virus-associated gastric cancer (EBVaGC) has long been regarded as the most immunologically favorable form of a disease that remains...

A new economic evaluation published in BMC Health Services Research concludes that ivonescimab plus chemotherapy, an emerging first-line option for...

An ancillary analysis of the Japanese phase III trial JCOG1013 found that a tumor proportion score of at least 1%...

A new Oncotarget case report details how the WIN Consortium's international molecular tumor board evaluated investigational EGFR, MDM2, CDK4/6 and...

In one of the rarest leukemia sequences ever documented, physicians in Iran report that a boy who recovered from Philadelphia-positive...

A six-month follow-up study of 84 patients with pancreatic cancer not candidates for surgical resection found that CT-guided iodine-125 particle...

A re-analysis of a placebo-controlled cross-over trial suggests that combining the proton pump inhibitor esomeprazole with the iron chelator deferasirox...

A combined bulk and single-cell transcriptomic study identifies FLT3 and AIM2 among immune-associated genes in prostate cancer, while cell-line knockdown...